Doualt et al. showed that IL-33 can be used in place of IL-12 to potently induce the proliferation of PAg-activated Vγ9 T cells both in vitro and in vivo which prevented tumor growth in a mouse model of lymphoma [125,130]. The gene discussed is IL33; the disease is neoplasm.